| NCT03138980 |
Mobile Self-Management of Irritable Bowel Syndrome for Adolescents |
https://ClinicalTrials.gov/show/NCT03138980 |
Completed |
University of California, Los Angeles |
2016-09-22 |
| NCT04256551 |
Effects of a Novel Machine Learning Mobile App on Diet Adherence in Individuals Following the Low Fodmap Diet |
https://ClinicalTrials.gov/show/NCT04256551 |
Completed |
Arizona State University |
2020-06-01 |
| NCT03379064 |
Culturally Adapted Psychological Intervention for the Management of Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT03379064 |
Completed |
Pakistan Institute of Living and Learning |
2017-10-31 |
| NCT03449628 |
L. Casei DG® in Patients With Irritable Bowel Syndrome. |
https://ClinicalTrials.gov/show/NCT03449628 |
Recruiting |
SOFAR S.p.A. |
2019-12-31 |
| NCT03823742 |
Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program? |
https://ClinicalTrials.gov/show/NCT03823742 |
Recruiting |
Baylor College of Medicine |
2022-09-30 |
| NCT03822299 |
Effects of Faecal Microbiota Transplantation in Patients With IBS |
https://ClinicalTrials.gov/show/NCT03822299 |
Completed |
Helse Fonna |
2019-04-30 |
| NCT03359499 |
Impact of Bacillus Clausii Administration on Irritable Bowel Syndrome Patients |
https://ClinicalTrials.gov/show/NCT03359499 |
Completed |
Hospital Britanico |
2017-10-25 |
| NCT03333291 |
Fecal Transplantation in Patients With IBS |
https://ClinicalTrials.gov/show/NCT03333291 |
Completed |
Haukeland University Hospital |
2017-06-15 |
| NCT03332537 |
Precision Pain Self-Management in Young Adults With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT03332537 |
Completed |
University of Connecticut |
2018-12-31 |
| NCT03318614 |
Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster |
https://ClinicalTrials.gov/show/NCT03318614 |
Completed |
Universiti Sains Malaysia |
2015-12-31 |
| NCT03306381 |
The Effect of Dietary Intervention on Symptoms, Epigenetics, and Gut Microbiota in IBS |
https://ClinicalTrials.gov/show/NCT03306381 |
Completed |
Region Skane |
2019-02-28 |
| NCT03304041 |
Efficacy of Low-FODMAPs Dietary Therapy for Irritable Bowel Syndrome in China |
https://ClinicalTrials.gov/show/NCT03304041 |
Completed |
Sir Run Run Shaw Hospital |
2018-05-31 |
| NCT03300804 |
Dose Escalation Trial of Traditional Chinese Medicine for Irritable Bowel Syndrome (TCM- IBS) |
https://ClinicalTrials.gov/show/NCT03300804 |
Completed |
University of Maryland, Baltimore |
2011-03-31 |
| NCT03270085 |
Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption |
https://ClinicalTrials.gov/show/NCT03270085 |
Completed |
Mayo Clinic |
2019-05-31 |
| NCT03269032 |
Mediterranean Diet and the Gut Microbiome |
https://ClinicalTrials.gov/show/NCT03269032 |
Active, not recruiting |
Wake Forest University Health Sciences |
2020-12-31 |
| NCT03265002 |
Fibre and Gas in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT03265002 |
Completed |
University of Nottingham |
2019-10-16 |
| NCT03251625 |
Multi-strain Probiotic in the Management of IBS-D |
https://ClinicalTrials.gov/show/NCT03251625 |
Completed |
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
2016-04-30 |
| NCT03245645 |
FODMAP Reintroduction in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT03245645 |
Enrolling by invitation |
University of California, Los Angeles |
2020-10-24 |
| NCT03219528 |
A Longitudinal Study to Identify IBS Phenotypes Using Fecal Microbiota and Hydrogen Breath Testing |
https://ClinicalTrials.gov/show/NCT03219528 |
Recruiting |
University of Michigan |
2021-12-31 |
| NCT03186872 |
Improving Quality of Care With a Digital Behavioral Program in IBD Patient Centered Medical Home |
https://ClinicalTrials.gov/show/NCT03186872 |
Completed |
University of Pittsburgh |
2019-05-29 |
| NCT03154086 |
A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT03154086 |
Completed |
GlaxoSmithKline |
2018-03-05 |
| NCT03150212 |
Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype |
https://ClinicalTrials.gov/show/NCT03150212 |
Completed |
Lesaffre International |
2019-05-09 |
| NCT03125564 |
FMT for Patients With IBS With Fecal and Mucosal Microbiota Assessment |
https://ClinicalTrials.gov/show/NCT03125564 |
Active, not recruiting |
Chinese University of Hong Kong |
2020-12-31 |
| NCT03099785 |
Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D |
https://ClinicalTrials.gov/show/NCT03099785 |
Recruiting |
Cosmo Pharmaceuticals NV |
2020-05-31 |
| NCT03087799 |
Brief Behavioral Treatment for Sleep Problems in IBS Study |
https://ClinicalTrials.gov/show/NCT03087799 |
Completed |
Beth Israel Deaconess Medical Center |
2019-08-08 |
| NCT03078634 |
The Multi-disciplinary Treatment of Functional Gut Disorders Study |
https://ClinicalTrials.gov/show/NCT03078634 |
Active, not recruiting |
St Vincent’s Hospital Melbourne |
2019-02-28 |
| NCT03074227 |
The FAIS-Trial: Faecal Microbiota Transplantation (FMT) in Adolescents With Refractory Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT03074227 |
Recruiting |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2021-04-01 |
| NCT04454996 |
Study on the Rule and Mechanism of Treating Functional Gastrointestinal Diseases From the Perspective of Liver and Spleen |
https://ClinicalTrials.gov/show/NCT04454996 |
Recruiting |
Xiyuan Hospital of China Academy of Chinese Medical Sciences |
2021-09-30 |
| NCT03054506 |
The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation |
https://ClinicalTrials.gov/show/NCT03054506 |
Completed |
Massachusetts General Hospital |
2018-05-10 |
| NCT03052439 |
Diet Reintroduction Study in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT03052439 |
Recruiting |
University of Michigan |
2020-10-31 |
| NCT03046667 |
Effect of 6 Weeks Daily Consumption of a Cereal-based Juice Beverage on Gastrointestinal Health |
https://ClinicalTrials.gov/show/NCT03046667 |
Completed |
University of Copenhagen |
2017-07-20 |
| NCT03035799 |
Comparing Two Types of Diets on Psychological and Gastrointestinal Symptoms |
https://ClinicalTrials.gov/show/NCT03035799 |
Completed |
Johns Hopkins University |
2020-04-01 |
| NCT03019861 |
Ayurvedic Nutritional Counseling for Patients With IBS in Comparison to Conventional Nutritional Counseling |
https://ClinicalTrials.gov/show/NCT03019861 |
Completed |
Charite University, Berlin, Germany |
2018-10-31 |
| NCT03011593 |
Effect of UGIR in Adults With Compromised Gut Function and Malabsorption |
https://ClinicalTrials.gov/show/NCT03011593 |
Completed |
Metagenics, Inc. |
2016-06-30 |
| NCT02980406 |
The Role of FODMAPs in Upper GI Effects, Colonic Motor Activity and Gut-brain Signaling at the Behavioral Level |
https://ClinicalTrials.gov/show/NCT02980406 |
Completed |
Universitaire Ziekenhuizen Leuven |
2016-06-30 |
| NCT02977975 |
Lacto-fermented Sauerkraut in the Treatment of Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02977975 |
Completed |
University of Copenhagen |
2017-03-31 |
| NCT02970591 |
A Comparison of Three Different Treatment Options for Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02970591 |
Recruiting |
Sahlgrenska University Hospital, Sweden |
2021-12-31 |
| NCT02959983 |
Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use |
https://ClinicalTrials.gov/show/NCT02959983 |
Completed |
Allergan |
2018-01-22 |
| NCT02932111 |
Irritable Bowel Syndrome and Osteopathic Manipulative Therapy |
https://ClinicalTrials.gov/show/NCT02932111 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2021-07-12 |
| NCT02924493 |
Dietary Treatment of Endometriosis-related Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02924493 |
Completed |
University of Aarhus |
2017-12-01 |
| NCT02888392 |
The Effect of Zespri Green Kiwifruit on Digestive and Gut Health Functions |
https://ClinicalTrials.gov/show/NCT02888392 |
Completed |
Zespri International Limited |
2017-01-30 |
| NCT03226145 |
Reclassifying Constipation Using Imaging and Manometry |
https://ClinicalTrials.gov/show/NCT03226145 |
Recruiting |
University of Nottingham |
2020-09-30 |
| NCT02880332 |
Pain Processing and Pain Neuroscience Education in Children With Chronic Abdominal Pain |
https://ClinicalTrials.gov/show/NCT02880332 |
Completed |
Vrije Universiteit Brussel |
2018-10-04 |
| NCT02875847 |
Effects of HMOs on Faecal Microbiota, Gastrointestinal Symptoms, Mucosal Immunity and Barrier Function in IBS Patients |
https://ClinicalTrials.gov/show/NCT02875847 |
Completed |
Glycom A/S |
2018-07-31 |
| NCT02868983 |
Integrating Behavioral Health and Primary Care for Comorbid Behavioral and Medical Problems |
https://ClinicalTrials.gov/show/NCT02868983 |
Enrolling by invitation |
University of Vermont |
2021-04-30 |
| NCT02857257 |
Transplantation of Anaerobic Cultured Human Intestinal Microbiota in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02857257 |
Recruiting |
Uppsala University |
2018-12-31 |
| NCT02847481 |
A Study to Evaluate Fecal Microbiota Transplantation Engraftment in IBS |
https://ClinicalTrials.gov/show/NCT02847481 |
Completed |
Beth Israel Deaconess Medical Center |
2018-08-05 |
| NCT02822118 |
Therapeutic Effect of Chang’an I Recipe on Irritable Bowel Syndrome With Diarrhea |
https://ClinicalTrials.gov/show/NCT02822118 |
Completed |
Xiyuan Hospital of China Academy of Chinese Medical Sciences |
2015-12-31 |
| NCT02802241 |
Effects of Open-label vs Double-blind Treatment in IBS |
https://ClinicalTrials.gov/show/NCT02802241 |
Completed |
Beth Israel Deaconess Medical Center |
2019-01-31 |
| NCT02798991 |
A Phase I, Randomized, Placebo-controlled, Double Blind, Repeat Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic Biomarkers of GSK3179106 in Normal Subjects |
https://ClinicalTrials.gov/show/NCT02798991 |
Completed |
GlaxoSmithKline |
2016-11-30 |
| NCT02794376 |
Mindfulness for Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02794376 |
Completed |
University of Oxford |
2017-07-10 |
| NCT02788071 |
Effect of Fecal Microbiota Transplantation in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02788071 |
Completed |
Aleris-Hamlet Hospitaler København |
2017-07-31 |
| NCT02757105 |
Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) |
https://ClinicalTrials.gov/show/NCT02757105 |
Completed |
RedHill Biopharma Limited |
2017-06-16 |
| NCT02737410 |
Resilience in Irritable Bowel Syndrome and Gut-focused Hypnotherapy |
https://ClinicalTrials.gov/show/NCT02737410 |
Completed |
Medical University of Vienna |
2014-06-30 |
| NCT02732743 |
Food Supplement Physiomanna® Baby in Pediatric Patients |
https://ClinicalTrials.gov/show/NCT02732743 |
Completed |
Iuppa Industriale Srl |
2016-04-30 |
| NCT02727751 |
A Long-Term Safety Study of Tenapanor for the Treatment of IBS-C |
https://ClinicalTrials.gov/show/NCT02727751 |
Completed |
Ardelyx |
2017-10-31 |
| NCT02727283 |
A Phase 1, Randomized, Placebo-Controlled, Ascending Cohort, Dose Escalation Study in Normal Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT02727283 |
Completed |
GlaxoSmithKline |
2016-03-18 |
| NCT02716285 |
Peppermint Oil for the Treatment of Irritable Bowel Syndrome: Optimizing Therapeutic Strategies Using Targeted Delivery |
https://ClinicalTrials.gov/show/NCT02716285 |
Completed |
Maastricht University Medical Center |
2018-05-01 |
| NCT02706483 |
Long Term Safety Study of Plecanatide |
https://ClinicalTrials.gov/show/NCT02706483 |
Completed |
Bausch Health Americas, Inc. |
2017-05-31 |
| NCT02686138 |
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C |
https://ClinicalTrials.gov/show/NCT02686138 |
Completed |
Ardelyx |
2017-08-31 |
| NCT02681666 |
Mindfulness-Based Eating in Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02681666 |
Completed |
University of Miami |
2017-12-26 |
| NCT02657668 |
Emotion Focused Therapy in Irritable Bowel Syndrome Patients |
https://ClinicalTrials.gov/show/NCT02657668 |
Completed |
Islamic Azad University, Najafabad Branch |
2014-01-31 |
| NCT02653937 |
The Effect of Shigyakusan Used for IBS and MUPS Diagnosed by Abdominal N Line Tenderness |
https://ClinicalTrials.gov/show/NCT02653937 |
Completed |
Nakatani Clinic |
2015-02-28 |
| NCT02651740 |
Gut Microbiota Reconstruction in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea |
https://ClinicalTrials.gov/show/NCT02651740 |
Recruiting |
Shanghai Zhongshan Hospital |
2020-04-30 |
| NCT02621892 |
A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C |
https://ClinicalTrials.gov/show/NCT02621892 |
Completed |
Ardelyx |
2017-03-31 |
| NCT02614313 |
Fructose Breath-testing in Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT02614313 |
Completed |
Brain-Gut Research Group |
2017-08-31 |
| NCT02609529 |
SBI in Children With d-IBS |
https://ClinicalTrials.gov/show/NCT02609529 |
Completed |
Louisiana State University Health Sciences Center in New Orleans |
2017-03-31 |
| NCT02590432 |
An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation |
https://ClinicalTrials.gov/show/NCT02590432 |
Completed |
Forest Laboratories |
2018-02-05 |
| NCT02572908 |
Effects of Wheat Breads on Symptoms of IBS, a Pilot Study |
https://ClinicalTrials.gov/show/NCT02572908 |
Completed |
Oy Karl Fazer Ab |
2016-03-31 |
| NCT03721107 |
A Trial for New Treatment of Adult Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT03721107 |
Completed |
4D pharma plc |
2020-05-15 |
| NCT02566876 |
Bifidobacteria In Children With Abdominal Pain-Associated Functional Gastrointestinal Disorders |
https://ClinicalTrials.gov/show/NCT02566876 |
Completed |
Federico II University |
2015-07-31 |
| NCT02559245 |
Effect of Flixweed and Fig on Irritable Bowel Syndrome With Predominant Constipation: a Single Blind Randomized Clinical Trial. |
https://ClinicalTrials.gov/show/NCT02559245 |
Completed |
Isfahan University of Medical Sciences |
2016-01-31 |
| NCT02559206 |
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) |
https://ClinicalTrials.gov/show/NCT02559206 |
Completed |
Ironwood Pharmaceuticals, Inc. |
2016-09-30 |
| NCT02877654 |
Is There Any Correlation Between Plasmatic Zonulin and Expression of Intestinal Tight Junction Proteins in IBS Patients? |
https://ClinicalTrials.gov/show/NCT02877654 |
Recruiting |
University Hospital, Rouen |
2021-02-28 |
| NCT02551029 |
fMRI and Visceral Perception Upon Capsaicin Infusion |
https://ClinicalTrials.gov/show/NCT02551029 |
Completed |
Maastricht University Medical Center |
2019-07-26 |
| NCT02538692 |
Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02538692 |
Completed |
Chengdu University of Traditional Chinese Medicine |
2017-01-31 |
| NCT02536131 |
Intestinal Microbiome and Psychological Correlates in Irritable Bowel Syndrome and Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT02536131 |
Completed |
Medical University of Vienna |
2016-08-31 |
| NCT02528929 |
Gluten-free Diet in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02528929 |
Completed |
Sheffield Teaching Hospitals NHS Foundation Trust |
2018-07-31 |
| NCT02493452 |
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C) |
https://ClinicalTrials.gov/show/NCT02493452 |
Completed |
Bausch Health Americas, Inc. |
2016-11-30 |
| NCT02493036 |
A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS-C |
https://ClinicalTrials.gov/show/NCT02493036 |
Completed |
Synthetic Biologics Inc. |
2015-12-31 |
| NCT02450370 |
Diets in Symptom Relief and the Influence of Quality of Life in People With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02450370 |
Completed |
Hong Kong Sanatorium & Hospital |
2017-11-20 |
| NCT02436603 |
Integrative Approaches to Managing Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT02436603 |
Completed |
Beth Israel Medical Center |
2017-06-28 |
| NCT02431533 |
The Efficacy of PX0612 In The Treatment Of Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02431533 |
Completed |
Pharmabiotix Inc |
2018-08-31 |
| NCT02421627 |
Moxibustion for Diarrhea-predominant Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02421627 |
Completed |
Shanghai Institute of Acupuncture, Moxibustion and Meridian |
2018-12-31 |
| NCT02420158 |
Trans-cutaneous Vagal Nerve Electrical Stimulation and Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02420158 |
Completed |
Hospices Civils de Lyon |
2018-08-31 |
| NCT02419963 |
Analyzing IBS to Identify Biomarkers and Microbiome Signatures |
https://ClinicalTrials.gov/show/NCT02419963 |
Completed |
Mayo Clinic |
2016-12-12 |
| NCT02391220 |
Assessment of the Symbiotic Fermented Milk in Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02391220 |
Completed |
Clinres Farmacija d.o.o. |
2013-01-31 |
| NCT02389998 |
Efficacy of Open Label Placebo in Children With FGIDs |
https://ClinicalTrials.gov/show/NCT02389998 |
Recruiting |
Boston Children’s Hospital |
2018-12-31 |
| NCT02388269 |
A Randomized, Single Centre, Double-blind, Parallel, Sham-controlled Pilot Study Using gammaCore®-G |
https://ClinicalTrials.gov/show/NCT02388269 |
Completed |
ElectroCore INC |
2015-05-31 |
| NCT02387359 |
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) |
https://ClinicalTrials.gov/show/NCT02387359 |
Completed |
Bausch Health Americas, Inc. |
2016-12-31 |
| NCT02372201 |
Effects of Fasting and Hydro Colon Therapy Plus Probiotics on GI Microbiota in Intolerances and Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02372201 |
Completed |
University of Vienna |
2014-06-30 |
| NCT02371499 |
Effect of Lactobacillus Casei DG (Enterolactis Plus®) in Patient With Irritable Bowel Syndrome: a Pilot Study |
https://ClinicalTrials.gov/show/NCT02371499 |
Completed |
SOFAR S.p.A. |
2015-11-30 |
| NCT02364830 |
Clinical Effectiveness of Enteric Coated(E.C.) Anise-oil on Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02364830 |
Completed |
Shiraz University of Medical Sciences |
2015-01-31 |
| NCT02358694 |
Safety and Tolerability of Serum Derived Bovine Immunoglobulin in Children With Diarrhea Predominant IBS |
https://ClinicalTrials.gov/show/NCT02358694 |
Completed |
Connecticut Children’s Medical Center |
2015-06-01 |
| NCT02358564 |
Gut Permeability, Sensitivity and Symptomatology |
https://ClinicalTrials.gov/show/NCT02358564 |
Active, not recruiting |
Mayo Clinic |
2020-08-31 |
| NCT02328547 |
Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02328547 |
Completed |
Montefiore Medical Center |
2017-10-31 |
| NCT02316899 |
Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02316899 |
Completed |
Astellas Pharma Inc |
2015-09-19 |
| NCT02306369 |
Internet-delivered CBT for Irritable Bowel Syndrome in Adolescents |
https://ClinicalTrials.gov/show/NCT02306369 |
Completed |
Karolinska Institutet |
2016-05-31 |
| NCT02299973 |
Fecal Microbiota Transplantation in Irritable Bowel Syndrome With Bloating |
https://ClinicalTrials.gov/show/NCT02299973 |
Completed |
University Hospital, Ghent |
2017-12-31 |
| NCT02294760 |
Long-term Sacral Nerve Stimulation for Irritable Bowel Syndrome. |
https://ClinicalTrials.gov/show/NCT02294760 |
Completed |
University of Aarhus |
2016-12-31 |
| NCT02291445 |
Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®), a Pharmacokinetic Study |
https://ClinicalTrials.gov/show/NCT02291445 |
Completed |
Maastricht University Medical Center |
2015-07-31 |
| NCT02270268 |
Effects of Pectin Supplementation in Diarrhea-predominant Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02270268 |
Completed |
Nanjing PLA General Hospital |
2013-10-31 |
| NCT02259465 |
The Effect of the Low FODMAP Diet and Dietary Oligofructose on Gastrointestinal Form, Function and Microbiota |
https://ClinicalTrials.gov/show/NCT02259465 |
Completed |
University of Nottingham |
2014-12-31 |
| NCT02254629 |
The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients |
https://ClinicalTrials.gov/show/NCT02254629 |
Completed |
Shandong University |
2015-08-31 |
| NCT02251483 |
Use of SBI in IBS Subjects Following a Successful Treatment of Small Intestinal Bacterial Overgrowth |
https://ClinicalTrials.gov/show/NCT02251483 |
Completed |
Cedars-Sinai Medical Center |
2015-07-31 |
| NCT02242175 |
Efficacy of Hydrogen Breath Test in the Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02242175 |
Recruiting |
Yonsei University |
2020-08-31 |
| NCT02220348 |
A Lactation Study in Women Who Are Breastfeeding or Pumping and Are Receiving Linaclotide Therapeutically |
https://ClinicalTrials.gov/show/NCT02220348 |
Completed |
Forest Laboratories |
2019-05-31 |
| NCT02213172 |
Evaluation of the Efficacy of Two Probiotic Strains for Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02213172 |
Completed |
KGK Science Inc. |
2018-02-15 |
| NCT02204891 |
Probiotics in Intestinal Bacterial Overgrowth |
https://ClinicalTrials.gov/show/NCT02204891 |
Completed |
University of Athens |
2016-06-30 |
| NCT02163213 |
Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g Bid on Nutritional Status in Subjects With IBS-D |
https://ClinicalTrials.gov/show/NCT02163213 |
Completed |
Mayo Clinic |
2016-11-01 |
| NCT02161120 |
Effect of Two Different Rye Bread Types in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02161120 |
Completed |
Oy Karl Fazer Ab |
2015-02-28 |
| NCT02136745 |
Effects of Relaxation Response Mind-body Intervention in Patients With IBS and IBD |
https://ClinicalTrials.gov/show/NCT02136745 |
Completed |
Massachusetts General Hospital |
2011-07-31 |
| NCT02113605 |
Cognitive Behavior Therapy (CBT) for Children With Functional Gastrointestinal Disorders |
https://ClinicalTrials.gov/show/NCT02113605 |
Completed |
Karolinska Institutet |
2015-11-30 |
| NCT02111603 |
Ability of Mayo Clinic High-performance Liquid Chromatography (HPLC) Method to Measure Fecal Bile Acids |
https://ClinicalTrials.gov/show/NCT02111603 |
Completed |
Mayo Clinic |
2014-08-31 |
| NCT02108119 |
The Effect of Probiotics on Symptoms and Intestinal Flora in Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02108119 |
Completed |
Probi AB |
2015-11-30 |
| NCT02107625 |
Traditional Dietary Advice Versus a Low FODMAP Diet Intake in IBS Patients |
https://ClinicalTrials.gov/show/NCT02107625 |
Completed |
Göteborg University |
2015-01-31 |
| NCT02107196 |
12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) |
https://ClinicalTrials.gov/show/NCT02107196 |
Completed |
Menarini Group |
2015-06-30 |
| NCT02092402 |
Fecal Microbiota Transplantation in Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02092402 |
Completed |
Örebro University, Sweden |
2016-11-30 |
| NCT02079857 |
Symptom Management for Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02079857 |
Recruiting |
NYU Langone Health |
2019-11-30 |
| NCT02079675 |
Study to Assess the Efficacy and Safety of SKI3246 in Subjects With Non-Constipation Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02079675 |
Completed |
SK Chemicals Co., Ltd. |
2014-03-31 |
| NCT02078323 |
Investigation of Linaclotide’s Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients |
https://ClinicalTrials.gov/show/NCT02078323 |
Completed |
Augusta University |
2017-10-04 |
| NCT02077699 |
Efficacy Evaluation of a Commercial Preparation Containing Lactobacillus Casei DG on the Reduction of the Painful Symptoms Related to the Irritable Bowel Syndrome (IBS). A Pilot Clinical Study |
https://ClinicalTrials.gov/show/NCT02077699 |
Completed |
SOFAR S.p.A. |
2014-06-30 |
| NCT02026518 |
Effect of Cholecalciferol, Soy Isoflavones in Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02026518 |
Completed |
Shahid Beheshti University of Medical Sciences |
2014-04-30 |
| NCT02074579 |
A Safety and Efficacy Study of Daikenchuto (TU-100) to Relieve Abdominal Bloating in Female Subjects With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02074579 |
Completed |
Tsumura USA |
2016-04-30 |
| NCT01316718 |
Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D) |
https://ClinicalTrials.gov/show/NCT01316718 |
Completed |
University of Nottingham |
2013-09-30 |
| NCT01303224 |
Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D) |
https://ClinicalTrials.gov/show/NCT01303224 |
Completed |
Menarini Group |
2012-05-31 |
| NCT01279382 |
Effect of Hypnotherapy in Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT01279382 |
Completed |
Maastricht University Medical Center |
NA |
| NCT01276626 |
Study of Bacteria on Mood and Bowel Symptoms in Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01276626 |
Completed |
Nestlé |
2014-06-30 |
| NCT01274000 |
A Study to Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female Patients |
https://ClinicalTrials.gov/show/NCT01274000 |
Completed |
Astellas Pharma Inc |
2011-10-31 |
| NCT02033161 |
Internet-delivered Cognitive Behavior Therapy for Adolescents With Functional Gastrointestinal Disorders: a Pilot Study |
https://ClinicalTrials.gov/show/NCT02033161 |
Completed |
Karolinska Institutet |
2013-06-30 |
| NCT02009618 |
The Effects of Rifaximin Therapy in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02009618 |
Completed |
Bezmialem Vakif University |
2013-10-31 |
| NCT01950715 |
Multimodal Stimulation Before and After Sacral Nerve Stimulation for Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01950715 |
Completed |
University of Aarhus |
2018-03-31 |
| NCT01948973 |
Subsensory Sacral Nerve Stimulation for Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01948973 |
Completed |
University of Aarhus |
2018-03-31 |
| NCT01923428 |
The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C) |
https://ClinicalTrials.gov/show/NCT01923428 |
Completed |
Ardelyx |
2014-10-31 |
| NCT04373304 |
The Effect of a Low FODMAP Diet in Irritable Bowel Syndrome Patients |
https://ClinicalTrials.gov/show/NCT04373304 |
Recruiting |
Universitaire Ziekenhuizen Leuven |
2021-07-01 |
| NCT01896583 |
A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) |
https://ClinicalTrials.gov/show/NCT01896583 |
Completed |
Seldar Pharma, Inc. |
2014-03-31 |
| NCT01890837 |
Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT01890837 |
Completed |
Tsumura USA |
2015-03-31 |
| NCT01887834 |
Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01887834 |
Completed |
The Canadian College of Naturopathic Medicine |
2014-06-30 |
| NCT01886781 |
Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01886781 |
Completed |
University of Stellenbosch |
2013-06-30 |
| NCT01886027 |
Stress Management for Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01886027 |
Completed |
Wayne State University |
2015-03-31 |
| NCT01880424 |
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) |
https://ClinicalTrials.gov/show/NCT01880424 |
Completed |
AstraZeneca |
2015-05-31 |
| NCT01870895 |
A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT01870895 |
Completed |
Astellas Pharma Inc |
2014-02-28 |
| NCT01855711 |
Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT01855711 |
Completed |
GlaxoSmithKline |
2005-05-10 |
| NCT01844180 |
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) |
https://ClinicalTrials.gov/show/NCT01844180 |
Completed |
Ono Pharmaceutical Co. Ltd |
2014-07-31 |
| NCT01837485 |
Probiotics in the Treatment of Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01837485 |
Completed |
Islamic Azad University, Najafabad Branch |
2013-01-31 |
| NCT01837472 |
Probiotics in the Treatment of Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01837472 |
Completed |
Isfahan University of Medical Sciences |
2013-01-31 |
| NCT01815164 |
Effect of Hypnotherapy and Educational Intervention in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01815164 |
Completed |
University Hospital, Linkoeping |
2011-09-30 |
| NCT01801605 |
Repetitive Transcranial Magnetic Stimulation in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01801605 |
Completed |
University Hospital, Rouen |
2013-01-31 |
| NCT01791621 |
The Diagnostic Predictability of Food Allergy Testing |
https://ClinicalTrials.gov/show/NCT01791621 |
Completed |
The Canadian College of Naturopathic Medicine |
2013-04-30 |
| NCT01786109 |
Effect of a Cannabinoid Agonist on Colonic Sensory Functions in Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01786109 |
Completed |
Mayo Clinic |
2011-12-31 |
| NCT01776853 |
Fructose and Fructans in Irritabla Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01776853 |
Completed |
University of Nottingham |
2015-02-28 |
| NCT01774825 |
IQP-CL-101 in IBS Management |
https://ClinicalTrials.gov/show/NCT01774825 |
Completed |
InQpharm Group |
2014-02-28 |
| NCT01774695 |
Physical Activity in IBS - a Long Term Follow up |
https://ClinicalTrials.gov/show/NCT01774695 |
Completed |
Sahlgrenska University Hospital, Sweden |
2011-09-30 |
| NCT01754493 |
Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression |
https://ClinicalTrials.gov/show/NCT01754493 |
Completed |
New York State Psychiatric Institute |
2014-12-31 |
| NCT01736423 |
A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01736423 |
Completed |
Astellas Pharma Inc |
2014-05-31 |
| NCT01728610 |
Effect of Probiotic Supplement in Alleviating Functional Gastrointestinal Symptoms |
https://ClinicalTrials.gov/show/NCT01728610 |
Completed |
Danisco |
2014-11-30 |
| NCT01726751 |
Spinal Cord Stimulation for Pain Relief in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01726751 |
Completed |
Uppsala University |
2014-04-30 |
| NCT01714843 |
A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01714843 |
Completed |
Astellas Pharma Inc |
2013-12-07 |
| NCT01699438 |
Mesalazine Treatment in IBS (The MIBS Study) |
https://ClinicalTrials.gov/show/NCT01699438 |
Completed |
Göteborg University |
2016-12-31 |
| NCT01641341 |
Irritable Bowel Syndrome Evaluation and Treatment in Primary Care |
https://ClinicalTrials.gov/show/NCT01641341 |
Completed |
American Academy of Family Physicians |
2012-03-31 |
| NCT01631500 |
Effects of an Integrative Treatment Model to Reduce Anxiety and Depression in Minor Mental Health Problems and Medically Unexplained Symptoms |
https://ClinicalTrials.gov/show/NCT01631500 |
Completed |
Göteborg University |
2011-01-31 |
| NCT01624610 |
Comparing the Effectiveness of 2 Diets for Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01624610 |
Completed |
University of Michigan |
2015-10-31 |
| NCT01622972 |
Mode of Action of Moviprep |
https://ClinicalTrials.gov/show/NCT01622972 |
Completed |
University of Nottingham |
2014-02-28 |
| NCT01619384 |
Mindfulness-Based Stress Reduction and the Microbiome |
https://ClinicalTrials.gov/show/NCT01619384 |
Completed |
Seattle Institute for Biomedical and Clinical Research |
2013-12-31 |
| NCT01613456 |
Effect of Saccharomyces Cerevisiae on the Symptoms of Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01613456 |
Completed |
Lesaffre International |
2013-06-30 |
| NCT01602575 |
Neuroimaging and Biomarkers in Chronic Visceral Pain |
https://ClinicalTrials.gov/show/NCT01602575 |
Completed |
University of California, Los Angeles |
2016-03-20 |
| NCT01553747 |
Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) |
https://ClinicalTrials.gov/show/NCT01553747 |
Completed |
Furiex Pharmaceuticals, Inc |
2014-01-09 |
| NCT01553591 |
Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) |
https://ClinicalTrials.gov/show/NCT01553591 |
Completed |
Furiex Pharmaceuticals, Inc |
2014-07-29 |
| NCT01551225 |
Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder |
https://ClinicalTrials.gov/show/NCT01551225 |
Completed |
Maastricht University Medical Center |
2016-09-30 |
| NCT01545037 |
Effect of BIO-K+ on Symptoms of Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01545037 |
Completed |
Bio-K Plus International Inc. |
2015-01-31 |
| NCT01543178 |
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study |
https://ClinicalTrials.gov/show/NCT01543178 |
Completed |
Bausch Health Americas, Inc. |
2014-06-30 |
| NCT01529567 |
Cognitive Behavioral Therapy With Our Without Exposure Therapy for Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01529567 |
Completed |
Karolinska Institutet |
2012-12-31 |
| NCT01507922 |
Comparative Efficacy and Safety of Fenoverine |
https://ClinicalTrials.gov/show/NCT01507922 |
Completed |
Bukwang Pharmaceutical |
2013-03-31 |
| NCT01505777 |
Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea |
https://ClinicalTrials.gov/show/NCT01505777 |
Completed |
Hanmi Pharmaceutical Company Limited |
2012-06-30 |
| NCT01494233 |
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01494233 |
Completed |
Lexicon Pharmaceuticals |
2013-09-30 |
| NCT01483287 |
The Effects of Added Enzyme α-Galactosidase at a Carbohydrate-rich Meal in Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT01483287 |
Completed |
Sahlgrenska University Hospital, Sweden |
2013-06-30 |
| NCT01418066 |
Ayurvedic Herbs in Diarrhea Predominant Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01418066 |
Completed |
Universität Duisburg-Essen |
2012-12-31 |
| NCT01418053 |
The Effect of Hot Cataplasm With Caraway Oil in the Treatment of Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01418053 |
Completed |
Universität Duisburg-Essen |
2013-09-30 |
| NCT01414244 |
Glutamine for the Treatment of Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01414244 |
Completed |
Tulane University |
2015-12-30 |
| NCT01412372 |
The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study |
https://ClinicalTrials.gov/show/NCT01412372 |
Completed |
University of Utah |
2019-04-22 |
| NCT01411800 |
An Open-Label Study of Two Formulations of LX1033 in Healthy Human Subjects |
https://ClinicalTrials.gov/show/NCT01411800 |
Completed |
Lexicon Pharmaceuticals |
2011-10-31 |
| NCT01404923 |
Effectiveness of On-demand Meteospasmyl® Use in Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT01404923 |
Completed |
Laboratoires Mayoly Spindler |
2011-10-31 |
| NCT01403493 |
Multidisciplinary Versus a Nurse Based Patient Education For Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01403493 |
Completed |
Sahlgrenska University Hospital, Sweden |
2011-07-31 |
| NCT01400048 |
Aloe Vera in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01400048 |
Completed |
Sahlgrenska University Hospital, Sweden |
2016-12-31 |
| NCT01350570 |
Acupuncture for Patients With Diarrhea-predominant IBS or Functional Diarrhea: a Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT01350570 |
Completed |
Chengdu University of Traditional Chinese Medicine |
2014-02-28 |
| NCT01342718 |
Effect of Herbal Extract Granules Combined With Probiotics on Irritable Bowel Syndrome With Diarrhea |
https://ClinicalTrials.gov/show/NCT01342718 |
Completed |
Kyunghee University Medical Center |
2012-04-30 |
| NCT01340053 |
A Study to Evaluate the Safety and Efficacy of RDX5791 for the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS-C) |
https://ClinicalTrials.gov/show/NCT01340053 |
Completed |
Ardelyx |
2011-12-31 |
| NCT01331213 |
Pregabalin on Colonic Motor and Sensory Function in Constipation Predominant Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01331213 |
Completed |
Mayo Clinic |
2013-02-28 |
| NCT01327300 |
Efficacy of Mesalamine in Diarrhea-predominant Irritable Bowel Syndrome (dIBS) |
https://ClinicalTrials.gov/show/NCT01327300 |
Completed |
University of Florida |
2012-03-31 |
| NCT04422327 |
The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT04422327 |
Completed |
PrecisionBiotics Ltd. |
2018-02-12 |
| NCT04387383 |
Acupuncture for Irritable Bowel Syndrome Patients |
https://ClinicalTrials.gov/show/NCT04387383 |
Recruiting |
Hong Kong Baptist University |
2021-04-30 |
| NCT04348760 |
Study of Inflammatory Markers and Symptom Severity in Personalized Nutritional Intervention in IBS |
https://ClinicalTrials.gov/show/NCT04348760 |
Completed |
GEK Srl |
2019-07-30 |
| NCT04340661 |
Effects of a Food Supplement Composed by BIOintestil ® (Bionocol®) on Microbiota and Inflammatory Profile in Irritable Bowel Syndrome Patients |
https://ClinicalTrials.gov/show/NCT04340661 |
Recruiting |
Targeting Gut Disease S.R.L. |
2020-09-30 |
| NCT04307368 |
The Impact of Dietary Treatment in Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT04307368 |
Completed |
Medical University of Bialystok |
2018-12-31 |
| NCT04283487 |
Brain and Gut Responses to Intragastric Administration of FODMAPs in Healthy Subjects and Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT04283487 |
Recruiting |
Universitaire Ziekenhuizen Leuven |
2020-06-30 |
| NCT04270487 |
The DOMINO Trial: Diet Or Medication in Irritable Bowel syNdrOme |
https://ClinicalTrials.gov/show/NCT04270487 |
Recruiting |
Universitaire Ziekenhuizen Leuven |
2020-03-01 |
| NCT04245254 |
GutMe!: IBS and Collagen Protein Powder an Interventional Study |
https://ClinicalTrials.gov/show/NCT04245254 |
Recruiting |
ProofPilot |
2020-08-01 |
| NCT04236843 |
Faecal Microbiota Transplantation (FMT) in Patients With IBSmechanism(s) of Action |
https://ClinicalTrials.gov/show/NCT04236843 |
Recruiting |
Helse Fonna |
2020-12-31 |
| NCT04225104 |
Yogic Breathing and IBS |
https://ClinicalTrials.gov/show/NCT04225104 |
Recruiting |
Texas State University |
2020-02-01 |
| NCT04217733 |
Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT04217733 |
Recruiting |
Tanta University |
2030-12-01 |
| NCT04206410 |
Effectiveness of Probiotics Stabilized With Cryoprotection Technology in Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT04206410 |
Completed |
Children’s Memorial Health Institute, Poland |
2019-09-10 |
| NCT04193501 |
Frequency of Sleep Abnormalities in Patients With Irritable Bowel Syndrome and Effect of Pharmacological Intervention |
https://ClinicalTrials.gov/show/NCT04193501 |
Recruiting |
Sanjay Gandhi Postgraduate Institute of Medical Sciences |
2021-02-28 |
| NCT04170686 |
Acceptability and Efficacy of the Zemedy App for IBS |
https://ClinicalTrials.gov/show/NCT04170686 |
Recruiting |
University of Pennsylvania |
2020-10-28 |
| NCT04159311 |
Osteopathy on IBS Symptoms in Patients With Ulcerative Colitis in Remission |
https://ClinicalTrials.gov/show/NCT04159311 |
Recruiting |
Clinique Paris-Bercy |
2021-11-02 |
| NCT04145856 |
Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico |
https://ClinicalTrials.gov/show/NCT04145856 |
Completed |
Hospital Juarez de Mexico |
2019-05-02 |
| NCT04143633 |
Low FODMAP Diet on Nutritional Status, Disease Activity and Gut Microbiota in IBS and UC With Normal or Overweight BMI |
https://ClinicalTrials.gov/show/NCT04143633 |
Recruiting |
Hospital General de Mexico |
2020-08-31 |
| NCT04138186 |
G-PUR® for Symptomatic Treatment in Irritable Bowel Syndrome With Diarrhea |
https://ClinicalTrials.gov/show/NCT04138186 |
Recruiting |
Glock Health, Science and Research GmbH |
2020-08-31 |
| NCT04133519 |
Efficacy and Safety of IBS Digital Behavioral Treatment |
https://ClinicalTrials.gov/show/NCT04133519 |
Recruiting |
metaMe Health |
2020-06-30 |
| NCT04132804 |
Effect of Tai Chi as Treatment for IBS-C |
https://ClinicalTrials.gov/show/NCT04132804 |
Recruiting |
Massachusetts General Hospital |
2021-08-01 |
| NCT04129762 |
Effect of a Diet Without Non-caloric Sweeteners on Gastrointestinal Symptoms in Patients With IBS and Dyspepsia |
https://ClinicalTrials.gov/show/NCT04129762 |
Recruiting |
Hospital General de Mexico |
2020-08-31 |
| NCT04122586 |
Mechanism of PERK - eIF2a Pathways in Intestinal Mucosal Barrier of IBS-D and the Role “Metabolism Ingredients” of Tongxieyaofang |
https://ClinicalTrials.gov/show/NCT04122586 |
Recruiting |
Xiyuan Hospital of China Academy of Chinese Medical Sciences |
2020-12-31 |
| NCT03339128 |
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children. |
https://ClinicalTrials.gov/show/NCT03339128 |
Recruiting |
Allergan |
2023-01-01 |
| NCT04095988 |
Allogeneic Microbiota-reconstitution (AMR) in Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) |
https://ClinicalTrials.gov/show/NCT04095988 |
Active, not recruiting |
University of Ulm |
2020-12-31 |
| NCT04072991 |
A Study Comparing the Effectiveness and Convenience of Dietary Therapy for Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT04072991 |
Active, not recruiting |
Sheffield Teaching Hospitals NHS Foundation Trust |
2020-11-30 |
| NCT04053790 |
Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D) |
https://ClinicalTrials.gov/show/NCT04053790 |
Recruiting |
Hospital General de Mexico |
2020-01-31 |
| NCT04043455 |
Olorinab in IBS-C and IBS-D |
https://ClinicalTrials.gov/show/NCT04043455 |
Recruiting |
Arena Pharmaceuticals |
2020-12-31 |
| NCT04043208 |
Treatment of Functional Abdominal Distension |
https://ClinicalTrials.gov/show/NCT04043208 |
Recruiting |
Hospital Universitari Vall d’Hebron Research Institute |
2020-06-19 |
| NCT04037826 |
L. Reuteri DSM 17938 and L. Reuteri ATCC PTA 6475 in Moderate to Severe Irritable Bowel in Adults |
https://ClinicalTrials.gov/show/NCT04037826 |
Active, not recruiting |
Innovacion y Desarrollo de Estrategias en Salud |
2018-09-30 |
| NCT04017585 |
Identification of Gluten Sensitivity in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT04017585 |
Completed |
University of Bari |
2019-09-30 |
| NCT04014413 |
Safety and Efficacy of Fecal Microbiota Transplantation |
https://ClinicalTrials.gov/show/NCT04014413 |
Recruiting |
Chinese University of Hong Kong |
2023-10-31 |
| NCT04011943 |
Fecal Microbiota Transplantation for Health Improvement (TFM3) |
https://ClinicalTrials.gov/show/NCT04011943 |
Enrolling by invitation |
Federal Research and Clinical Center of Physical-Chemical Medicine |
2020-12-01 |
| NCT04008901 |
The Efficacy and Safety of “BST104” (Lonicera Flos Extract) in Mild to Moderate Functional Dyspepsia Subjects |
https://ClinicalTrials.gov/show/NCT04008901 |
Completed |
Seoul National University Bundang Hospital |
2018-07-02 |
| NCT03997708 |
A Mediterranean Approach to Low FODMAP Diet (MED-LFD) for Managing IBS Symptoms |
https://ClinicalTrials.gov/show/NCT03997708 |
Recruiting |
Attikon Hospital |
2021-06-03 |
| NCT03986476 |
The Effect of Two Probiotic Products on the Intestinal Barrier Function in Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT03986476 |
Recruiting |
Örebro University, Sweden |
2020-06-30 |
| NCT03977155 |
Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) |
https://ClinicalTrials.gov/show/NCT03977155 |
Active, not recruiting |
Boston Pharmaceuticals |
2020-04-30 |
| NCT03964103 |
qQ-lab Daily-IBS for Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT03964103 |
Completed |
IlDong Pharmaceutical Co Ltd |
2017-11-08 |
| NCT03948854 |
Implementing a Low FODMAP Diet in Irritable Bowel Syndrome Patients |
https://ClinicalTrials.gov/show/NCT03948854 |
Enrolling by invitation |
Mayo Clinic |
2020-05-22 |
| NCT03931785 |
A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT03931785 |
Completed |
Ironwood Pharmaceuticals, Inc. |
2020-02-26 |
| NCT03931330 |
Does Improving Vagal Tone Increase Mitochondrial Bioenergetics |
https://ClinicalTrials.gov/show/NCT03931330 |
Completed |
Medical College of Wisconsin |
2019-09-24 |
| NCT03920410 |
Effect of Serotonergic Stimulation on the Gut-brain Axis |
https://ClinicalTrials.gov/show/NCT03920410 |
Recruiting |
Örebro University, Sweden |
2020-12-31 |
| NCT03899779 |
Face-to-face Versus Online Hypnotherapy for the Treatment of Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT03899779 |
Recruiting |
Maastricht University Medical Center |
2022-08-31 |
| NCT03869359 |
The Effect of Gluten in Patients With Irritable Bowel Syndrome and Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT03869359 |
Recruiting |
Sahlgrenska University Hospital, Sweden |
2019-10-01 |
| NCT03844412 |
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments |
https://ClinicalTrials.gov/show/NCT03844412 |
Recruiting |
Duke University |
2022-10-01 |
| NCT03817645 |
Panaceo “MED” for IBS (Irritable Bowel Syndrome) |
https://ClinicalTrials.gov/show/NCT03817645 |
Recruiting |
Scigenia GmbH |
2019-06-30 |
| NCT03815617 |
A Novel Formulation of Bifidobacterium Longum BB536 and Lactobacillus Rhamnosus HN001 With Vitamin B6 on IBS Patients |
https://ClinicalTrials.gov/show/NCT03815617 |
Completed |
University of Bari |
2018-05-31 |
| NCT03806959 |
Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy |
https://ClinicalTrials.gov/show/NCT03806959 |
Recruiting |
Hospital Avicenne |
2020-11-07 |
| NCT03806127 |
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT03806127 |
Recruiting |
Urovant Sciences GmbH |
2020-09-30 |
| NCT03803319 |
Effects of Dietary Fibre in Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT03803319 |
Completed |
King’s College London |
2020-01-11 |
| NCT03801057 |
Marine Protein Hydrolysate as Dietary Supplement in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT03801057 |
Completed |
Helse Møre og Romsdal HF |
2019-03-21 |
| NCT03763175 |
Efficacy and Safety of SYN-010 in IBS-C |
https://ClinicalTrials.gov/show/NCT03763175 |
Recruiting |
Cedars-Sinai Medical Center |
2020-10-30 |
| NCT03729622 |
Carbohydrate Reduction and Impact on Gastrointestinal System |
https://ClinicalTrials.gov/show/NCT03729622 |
Completed |
University of Nottingham |
2017-07-31 |
| NCT03729271 |
Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea |
https://ClinicalTrials.gov/show/NCT03729271 |
Recruiting |
University of Michigan |
2021-01-01 |
| NCT03694223 |
Health Education Delivery Methods for a Low Fermentable Carbohydrate Diet in Patients With Functional Bowel Disorders |
https://ClinicalTrials.gov/show/NCT03694223 |
Completed |
King’s College London |
2018-10-25 |
| NCT03687814 |
Low FODMAP Plus PEG 3350 for the Treatment of Patients With Irritable Bowel Syndrome-Constipation |
https://ClinicalTrials.gov/show/NCT03687814 |
Recruiting |
University of Michigan |
2020-11-03 |
| NCT03678935 |
Effect of FODMAP Restriction on Persistent GI-symptoms in Coeliac Patients |
https://ClinicalTrials.gov/show/NCT03678935 |
Active, not recruiting |
Oslo University Hospital |
2019-06-01 |
| NCT03675100 |
Neurotrophic Factors, Tight Junction Proteins, and Cytokines in IBS |
https://ClinicalTrials.gov/show/NCT03675100 |
Completed |
Seoul National University Bundang Hospital |
2019-12-31 |
| NCT03664531 |
Dietary Triggers of Gastrointestinal Symptoms in IBS Patients |
https://ClinicalTrials.gov/show/NCT03664531 |
Recruiting |
McMaster University |
2020-08-31 |
| NCT03644602 |
Low FODMAPs Diet in Gastrointestinal Disorders |
https://ClinicalTrials.gov/show/NCT03644602 |
Completed |
Federico II University |
2016-12-31 |
| NCT03638544 |
Reduced Content of Gluten Diet on Patients With Irritable Bowel Syndrome (Pro.Ali.Fun.) |
https://ClinicalTrials.gov/show/NCT03638544 |
Completed |
University of Bari |
2016-12-31 |
| NCT03613545 |
Fecal Microbiota Transplantation for Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT03613545 |
Recruiting |
Guangzhou First People’s Hospital |
2028-12-31 |
| NCT03596905 |
Efficacy and Safety of Plecanatide in Children 6 to <18 Years of Age With Irritable Bowel Syndrome With Constipation (IBS-C) |
https://ClinicalTrials.gov/show/NCT03596905 |
Recruiting |
Bausch Health Americas, Inc. |
2020-12-31 |
| NCT03586622 |
One Year Home Monitoring and Treatment of IBS Patients |
https://ClinicalTrials.gov/show/NCT03586622 |
Recruiting |
Nordsjaellands Hospital |
2020-07-16 |
| NCT03568513 |
Effect of Curcumin on Gut Microbiota in IBS |
https://ClinicalTrials.gov/show/NCT03568513 |
Recruiting |
Medical College of Wisconsin |
2022-03-31 |
| NCT03561519 |
FMT in the Treatment of IBS |
https://ClinicalTrials.gov/show/NCT03561519 |
Completed |
Joint Authority for Päijät-Häme Social and Health Care |
2018-07-01 |
| NCT03550742 |
Effect of HMOs as Nutritional Support for Normal Bowel Movements in IBS Patients |
https://ClinicalTrials.gov/show/NCT03550742 |
Completed |
Glycom A/S |
2019-03-20 |
| NCT03492333 |
Gluten Free Diet in IBS Patients Stratified According to Their Antigliadin Status |
https://ClinicalTrials.gov/show/NCT03492333 |
Completed |
McMaster University |
2016-05-30 |
| NCT03466281 |
Patient Education for Patients With Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT03466281 |
Completed |
Sahlgrenska University Hospital, Sweden |
2017-06-30 |
| NCT03462966 |
Rifaximin on Visceral Hypersensitivity |
https://ClinicalTrials.gov/show/NCT03462966 |
Recruiting |
Cedars-Sinai Medical Center |
2020-07-31 |
| NCT03459482 |
Endpoint Determination Study Protocol |
https://ClinicalTrials.gov/show/NCT03459482 |
Recruiting |
Biomerica |
2020-12-31 |
| NCT03457324 |
Efficacy and Safety of Chinese Medicine JCM-16021 for Diarrhea-predominant Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT03457324 |
Recruiting |
Hong Kong Baptist University |
2020-06-30 |
| NCT03454386 |
SMART Program in Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT03454386 |
Completed |
University of California, Los Angeles |
2019-11-07 |
| NCT03441581 |
3030-401-002 ELX BAM Study |
https://ClinicalTrials.gov/show/NCT03441581 |
Completed |
Allergan |
2020-04-29 |
| NCT03440255 |
Transcutaneous Vagus Nerve Stimulation in Private Healthcare Center |
https://ClinicalTrials.gov/show/NCT03440255 |
Completed |
Kinesis Health Associates |
2017-07-31 |
| NCT03432078 |
Individual vs. Group Hypnotherapy in Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT03432078 |
Active, not recruiting |
Sahlgrenska University Hospital, Sweden |
2019-12-31 |
| NCT03423069 |
Low FODMAPs Diet vs. Specific Dietary Advice in Patients With IBS Diarrheal Variant |
https://ClinicalTrials.gov/show/NCT03423069 |
Recruiting |
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis |
2019-07-30 |
| NCT01268709 |
Effect of Doxepin and Nortriptyline on Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01268709 |
Completed |
Qom University of Medical Sciences |
NA |
| NCT01253408 |
Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor Functions in Patients With Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT01253408 |
Completed |
Mayo Clinic |
2011-12-31 |
| NCT01252550 |
Effects of Activia in IBS |
https://ClinicalTrials.gov/show/NCT01252550 |
Completed |
Sahlgrenska University Hospital, Sweden |
2014-05-31 |
| NCT01248013 |
Irritable Bowel Syndrome Hypnotherapy |
https://ClinicalTrials.gov/show/NCT01248013 |
Completed |
Mind-Body Digestive Center |
2009-12-31 |
| NCT01225237 |
A Study to Evaluate Efficacy of Ramosetron on Diarrhea-predominant Irritable Bowel Syndrome (IBS) in Male Patients |
https://ClinicalTrials.gov/show/NCT01225237 |
Completed |
Astellas Pharma Inc |
2011-08-31 |
| NCT01205100 |
Treatment of Abdominal Distension by Biofeedback - a Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT01205100 |
Completed |
Hospital Universitari Vall d’Hebron Research Institute |
2016-01-31 |
| NCT01192672 |
Use of Expressive Writing in Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT01192672 |
Completed |
Boston University |
2010-09-30 |
| NCT01178593 |
Group Hypnosis for Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01178593 |
Completed |
Medical University of Vienna |
2010-09-30 |
| NCT01177410 |
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea |
https://ClinicalTrials.gov/show/NCT01177410 |
Completed |
Bausch Health Americas, Inc. |
2011-08-31 |
| NCT01176227 |
Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT01176227 |
Completed |
The Canadian College of Naturopathic Medicine |
2011-02-28 |
| NCT01171053 |
Internet-delivered CBT for Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01171053 |
Completed |
Karolinska Institutet |
2010-06-30 |
| NCT01166789 |
Lubiprostone Effects on Visceral Pain Sensitivity |
https://ClinicalTrials.gov/show/NCT01166789 |
Completed |
University of North Carolina, Chapel Hill |
2010-08-31 |
| NCT01162863 |
Effects of Lubiprostone on Gastrointestinal Transit & pH in Irritable Bowel Syndrome (IBS) With Constipation |
https://ClinicalTrials.gov/show/NCT01162863 |
Completed |
University of Michigan |
2012-12-31 |
| NCT01153295 |
“Functional Bowel Disorder. Investigation in General Practice” |
https://ClinicalTrials.gov/show/NCT01153295 |
Completed |
University of Southern Denmark |
2011-06-30 |
| NCT01151657 |
Probiotics for Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01151657 |
Completed |
University of Southern Denmark |
2011-06-30 |
| NCT01149200 |
Proof-of-Principle Study of TC-6499 in the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT01149200 |
Completed |
Targacept Inc. |
2010-10-31 |
| NCT01144832 |
Irritable Bowel Syndrome (IBS) Treatment With H1-receptor Antagonists |
https://ClinicalTrials.gov/show/NCT01144832 |
Completed |
KU Leuven |
2012-05-31 |
| NCT01139736 |
Manipulation of Visceral Hypersensitivity With Probiotic Bacteria in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01139736 |
Completed |
Chinese University of Hong Kong |
2011-03-31 |
| NCT01130272 |
Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea |
https://ClinicalTrials.gov/show/NCT01130272 |
Completed |
Furiex Pharmaceuticals, Inc |
2011-07-14 |
| NCT01127828 |
Effects of Cultura Yoghurt in Irritable Bowel Syndrome (IBS) Patients on Intestinal and Immunological Changes |
https://ClinicalTrials.gov/show/NCT01127828 |
Completed |
Good Food Practice, Sweden |
2006-05-31 |
| NCT01118988 |
Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents |
https://ClinicalTrials.gov/show/NCT01118988 |
Completed |
University of California, Los Angeles |
2011-06-30 |
| NCT01107977 |
Iyengar Yoga for Young People With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01107977 |
Completed |
University of California, Los Angeles |
2013-12-31 |
| NCT01100684 |
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) |
https://ClinicalTrials.gov/show/NCT01100684 |
Completed |
Tioga Pharmaceuticals |
2013-06-30 |
| NCT01095042 |
Cognition and Emotion in the SII and IBD |
https://ClinicalTrials.gov/show/NCT01095042 |
Completed |
University Hospital, Grenoble |
2013-05-31 |
| NCT01094041 |
Gluten Intolerance in Patients With Diarrhea Predominant Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01094041 |
Completed |
Mayo Clinic |
2012-01-31 |
| NCT01088971 |
Effect of Duolac 7S Administration on Improving Symptom in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01088971 |
Completed |
Cell Biotech Co., Ltd. |
2011-07-31 |
| NCT01085643 |
Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS) |
https://ClinicalTrials.gov/show/NCT01085643 |
Completed |
Cedars-Sinai Medical Center |
2010-12-31 |
| NCT01056107 |
Effects of ROSE-010 on GI Transit in Constipation Predominant Irritable Bowel Syndrome (C-IBS) Patients |
https://ClinicalTrials.gov/show/NCT01056107 |
Completed |
Mayo Clinic |
2011-12-31 |
| NCT01051973 |
Cognitive Behavior Therapy (CBT) Compared to Stress Management for Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01051973 |
Completed |
Karolinska Institutet |
2010-12-31 |
| NCT01050465 |
MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use |
https://ClinicalTrials.gov/show/NCT01050465 |
Completed |
University of Missouri-Columbia |
2010-10-31 |
| NCT01047800 |
Functional Gastrointestinal Disorder Screening Program - A Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT01047800 |
Completed |
Chinese University of Hong Kong |
2015-05-31 |
| NCT01027260 |
Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syndrome With Predominant Constipation |
https://ClinicalTrials.gov/show/NCT01027260 |
Completed |
Abbott |
2010-08-31 |
| NCT01018498 |
Pilot Study Using a Dietary Intervention for Children With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01018498 |
Completed |
Baylor College of Medicine |
2011-09-30 |
| NCT01010191 |
Harnessing Placebo Effects: Non-Deceptive Use of Placebo in Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT01010191 |
Completed |
Harvard University Faculty of Medicine |
2010-04-30 |
| NCT00977197 |
A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00977197 |
Completed |
Mayo Clinic |
2015-06-30 |
| NCT00971711 |
Safety Study of Probiotics in Adults With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00971711 |
Completed |
Baylor College of Medicine |
2013-12-31 |
| NCT00961298 |
An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder |
https://ClinicalTrials.gov/show/NCT00961298 |
Completed |
West Penn Allegheny Health System |
2011-12-31 |
| NCT00955994 |
Effect of Asimadoline, a Member of a New Medication Class, on Acute Attacks of Pain in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00955994 |
Completed |
Mayo Clinic |
2007-03-31 |
| NCT00948870 |
Trial of Chinese Prescription Shugan Decoction on Irritable Bowel Syndrome（Diarrhea Type） |
https://ClinicalTrials.gov/show/NCT00948870 |
Completed |
Shanghai University of Traditional Chinese Medicine |
2011-07-31 |
| NCT00948818 |
Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation |
https://ClinicalTrials.gov/show/NCT00948818 |
Completed |
Forest Laboratories |
2010-07-31 |
| NCT00945334 |
Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00945334 |
Completed |
Cedars-Sinai Medical Center |
2013-06-30 |
| NCT00938717 |
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) |
https://ClinicalTrials.gov/show/NCT00938717 |
Completed |
Ironwood Pharmaceuticals, Inc. |
2010-09-30 |
| NCT00934973 |
Management of Irritable Bowel Syndrome in Primary Care (MIBS Trial) |
https://ClinicalTrials.gov/show/NCT00934973 |
Completed |
University of Southampton |
2011-09-30 |
| NCT00934479 |
Intestinal Microecology in Chronic Constipation |
https://ClinicalTrials.gov/show/NCT00934479 |
Completed |
Mayo Clinic |
2012-02-29 |
| NCT00931294 |
Saliva Testosterone Increases in Irritable Bowel Syndrome (IBS) Patients Beginning Choir Singing |
https://ClinicalTrials.gov/show/NCT00931294 |
Completed |
Stockholm University |
2007-05-31 |
| NCT00919672 |
Treatment of Irritable Bowel Syndrome (IBS) With Sacral Nerve Stimulation |
https://ClinicalTrials.gov/show/NCT00919672 |
Completed |
University of Aarhus |
2012-06-30 |
| NCT00918411 |
A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00918411 |
Completed |
Astellas Pharma Inc |
2009-12-31 |
| NCT00912301 |
Cheno Effect on Transit in Health and IBS-C |
https://ClinicalTrials.gov/show/NCT00912301 |
Completed |
Mayo Clinic |
2009-11-30 |
| NCT00911612 |
Does Welchol (Colesevelam Hydrochloride) Improve Colonic Transit in Diarrhea-predominant Irritable Bowel Syndrome (D-IBS)? |
https://ClinicalTrials.gov/show/NCT00911612 |
Completed |
Mayo Clinic |
2009-05-31 |
| NCT00907790 |
Nursing Management of Irritable Bowel Syndrome (IBS) 2008 |
https://ClinicalTrials.gov/show/NCT00907790 |
Completed |
University of Washington |
2012-12-31 |
| NCT00900965 |
Effect of Electroacupuncture in Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00900965 |
Completed |
Chinese University of Hong Kong |
2008-12-31 |
| NCT00880594 |
Irritable Bowel Syndrome (IBS) Functional Magnetic Resonance Imaging (fMRI) With Desipramine |
https://ClinicalTrials.gov/show/NCT00880594 |
Active, not recruiting |
Washington University School of Medicine |
2020-05-31 |
| NCT00880256 |
Mindfulness-Based Stress Reduction for Bowel Symptoms: Collection of Pilot Survey Data |
https://ClinicalTrials.gov/show/NCT00880256 |
Completed |
Seattle Institute for Biomedical and Clinical Research |
2010-10-31 |
| NCT00844961 |
Effectiveness of Internet Delivered Cognitive Behavior Therapy (CBT) for Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT00844961 |
Completed |
Karolinska Institutet |
2011-02-28 |
| NCT03653689 |
Identification of IBS Metabotypes Based on Physiological Responses to Food |
https://ClinicalTrials.gov/show/NCT03653689 |
Completed |
Uppsala University |
2019-06-14 |
| NCT01722318 |
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) |
https://ClinicalTrials.gov/show/NCT01722318 |
Completed |
Bausch Health Americas, Inc. |
2014-04-30 |
| NCT00829218 |
Clinical Trial Examining Effects of Monosodium Glutamate (MSG) on Irritable Bowel Syndrome (IBS) and Fibromyalgia (FM) |
https://ClinicalTrials.gov/show/NCT00829218 |
Completed |
Oregon Health and Science University |
2009-11-30 |
| NCT04166058 |
Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C |
https://ClinicalTrials.gov/show/NCT04166058 |
Enrolling by invitation |
Allergan |
2023-02-28 |
| NCT00813098 |
Study of LX1031 in Subjects With Non-Constipating Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00813098 |
Completed |
Lexicon Pharmaceuticals |
2009-07-31 |
| NCT04296552 |
Brain-Gut-Microbiota Interaction in IBS |
https://ClinicalTrials.gov/show/NCT04296552 |
Recruiting |
Haukeland University Hospital |
2021-12-31 |
| NCT00806104 |
Fructo-oligosaccharides and Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00806104 |
Completed |
Beghin-Meiji |
2010-07-31 |
| NCT02550704 |
Association Between High Faecal Calprotectin, Increased Intestinal Permeability and Visceral Hypersensitivity in IBS-D Patients |
https://ClinicalTrials.gov/show/NCT02550704 |
Recruiting |
University Hospital, Rouen |
2020-10-31 |
| NCT03573908 |
A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) |
https://ClinicalTrials.gov/show/NCT03573908 |
Completed |
Ironwood Pharmaceuticals, Inc. |
2019-03-13 |
| NCT03225261 |
The Effect of Citrus Extract on Gastrointestinal Health |
https://ClinicalTrials.gov/show/NCT03225261 |
Recruiting |
Maastricht University Medical Center |
2020-12-31 |
| NCT03252743 |
ICBT for Pain-predominant FGIDs in Children and Adolescents: an Implementation Study. |
https://ClinicalTrials.gov/show/NCT03252743 |
Completed |
Karolinska Institutet |
2018-06-17 |
| NCT02721836 |
Yoga for Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02721836 |
Completed |
Universität Duisburg-Essen |
2016-12-31 |
| NCT01940848 |
Efficacy/Safety Study to Confirm Iberogast’s Efficacy in Patients With Irritable Bowel Syndrome Diagnosed on ROME III Criteria Compared to Placebo |
https://ClinicalTrials.gov/show/NCT01940848 |
Completed |
Bayer |
2017-10-25 |
| NCT02579902 |
Effect of Vitamin D3 Supplementation in Treatment of Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT02579902 |
Completed |
Ahvaz Jundishapur University of Medical Sciences |
2015-08-31 |
| NCT02495623 |
A Study of the Effect of SYN-010 on Subjects With IBS-C |
https://ClinicalTrials.gov/show/NCT02495623 |
Completed |
Synthetic Biologics Inc. |
2015-10-31 |
| NCT02186743 |
Irritable Bowel Syndrome and Food Sensitivity |
https://ClinicalTrials.gov/show/NCT02186743 |
Completed |
Yale University |
2016-01-31 |
| NCT02154867 |
Fecal Microbial Transplantation in Treatment of Irritable Bowel Syndrome; a Double Blinded Placebo Controlled Trial. |
https://ClinicalTrials.gov/show/NCT02154867 |
Completed |
University Hospital of North Norway |
2016-10-31 |
| NCT01829932 |
The Effect of Prebiotics on the Microbiome in Irritable Bowel Syndrome Patients: The Diet and Microbiome Study |
https://ClinicalTrials.gov/show/NCT01829932 |
Completed |
Queen’s University |
2014-12-31 |
| NCT04129619 |
A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D) |
https://ClinicalTrials.gov/show/NCT04129619 |
Recruiting |
OrphoMed, Inc. |
2021-10-31 |
| NCT00788658 |
Cognitive Behaviour Therapy for Patients With IBS |
https://ClinicalTrials.gov/show/NCT00788658 |
Completed |
Rabin Medical Center |
2010-12-31 |
| NCT00786123 |
Exploring the Mechanism of a Probiotic Combination VSL#3 in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00786123 |
Completed |
National University Hospital, Singapore |
2009-12-31 |
| NCT00779493 |
Curcumin (Tumeric) in the Treatment of Irritable Bowel Syndrome: A Randomized-Controlled Trial |
https://ClinicalTrials.gov/show/NCT00779493 |
Completed |
Kaiser Permanente |
2009-06-30 |
| NCT00774007 |
A Randomized Controlled Pilot Trial of Mesalazine in Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00774007 |
Completed |
SOFAR S.p.A. |
2005-11-30 |
| NCT00765999 |
An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation |
https://ClinicalTrials.gov/show/NCT00765999 |
Completed |
Forest Laboratories |
2012-01-31 |
| NCT00761007 |
Ibodutant for Relief of Irritable Bowel Syndrome (IRIS) |
https://ClinicalTrials.gov/show/NCT00761007 |
Completed |
Menarini Group |
2009-02-28 |
| NCT00745004 |
Ondansetron for the Treatment of IBS With Diarrhoea (IBS-D) |
https://ClinicalTrials.gov/show/NCT00745004 |
Completed |
University of Nottingham |
2011-07-31 |
| NCT00738920 |
Self Administered Cognitive Behavior Therapy for Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00738920 |
Completed |
State University of New York at Buffalo |
2016-12-31 |
| NCT00731679 |
Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT00731679 |
Completed |
Bausch Health Americas, Inc. |
2009-08-31 |
| NCT00731003 |
The Effect of Serotonergic Modulation on Intestinal Permeability and Visceral Hypersensitivity in Healthy Individuals and Irritable Bowel Syndrome (IBS) Patients |
https://ClinicalTrials.gov/show/NCT00731003 |
Completed |
Maastricht University Medical Center |
2011-05-31 |
| NCT00730171 |
An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation |
https://ClinicalTrials.gov/show/NCT00730171 |
Completed |
Ironwood Pharmaceuticals, Inc. |
2012-03-31 |
| NCT00724126 |
Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT00724126 |
Completed |
Bausch Health Americas, Inc. |
2009-08-31 |
| NCT00706758 |
Structured Patient Education Versus Written Information for Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00706758 |
Completed |
Sahlgrenska University Hospital, Sweden |
2008-06-30 |
| NCT00702026 |
The Effect of a Multispecies Probiotic on Hypersensitivity in Irritable Bowel Syndrome (IBS) Patients |
https://ClinicalTrials.gov/show/NCT00702026 |
Completed |
Maastricht University Medical Center |
2011-12-31 |
| NCT00699166 |
Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) |
https://ClinicalTrials.gov/show/NCT00699166 |
Completed |
Novartis |
2005-09-30 |
| NCT00693732 |
Validation of Surrogate Measures in Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT00693732 |
Completed |
National University Hospital, Singapore |
2012-01-31 |
| NCT00680836 |
Gulf War Digestive Health Study |
https://ClinicalTrials.gov/show/NCT00680836 |
Completed |
VA Office of Research and Development |
2008-10-31 |
| NCT00680693 |
Mindfulness vs. Support Groups for Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00680693 |
Completed |
University of North Carolina, Chapel Hill |
2010-08-31 |
| NCT00676975 |
The Efficacy of Tradition Chinese Medicine in Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00676975 |
Completed |
Chinese University of Hong Kong |
2010-12-30 |
| NCT02082457 |
Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation |
https://ClinicalTrials.gov/show/NCT02082457 |
Completed |
SK Chemicals Co., Ltd. |
2014-12-31 |
| NCT00634608 |
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow |
https://ClinicalTrials.gov/show/NCT00634608 |
Completed |
University of Missouri-Columbia |
2009-03-31 |
| NCT00626288 |
Mesalazine Therapy in Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00626288 |
Completed |
SOFAR S.p.A. |
2012-03-31 |
| NCT00616200 |
Effects of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT00616200 |
Completed |
University of North Carolina, Chapel Hill |
2010-05-31 |
| NCT00610909 |
Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT00610909 |
Completed |
Duke University |
2002-12-31 |
| NCT00589771 |
Saccharomyces Boulardii in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00589771 |
Completed |
Aga Khan University |
2011-12-31 |
| NCT00587860 |
A Placebo-Controlled Trial of St. John’s Wort for Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00587860 |
Completed |
Mayo Clinic |
2008-01-31 |
| NCT00584571 |
Randomized Controlled Trial of Treating Rectal Hypersensitivity - Comparing Escitalopram With Sensory Adaptation Training |
https://ClinicalTrials.gov/show/NCT00584571 |
Active, not recruiting |
Augusta University |
2015-12-31 |
| NCT00584298 |
Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide |
https://ClinicalTrials.gov/show/NCT00584298 |
Completed |
Novartis |
2009-04-30 |
| NCT00583128 |
Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00583128 |
Completed |
Ocera Therapeutics |
2010-05-31 |
| NCT00561535 |
Effect of a Probiotic, Lactobacillus FARCIMINIS, in Diarrhea Predominant IBS Patients |
https://ClinicalTrials.gov/show/NCT00561535 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2010-05-31 |
| NCT00555191 |
Fructose Malabsorption in Northern Norway |
https://ClinicalTrials.gov/show/NCT00555191 |
Completed |
University Hospital of North Norway |
2016-05-31 |
| NCT00554320 |
Effect of Repetitive Transcranial Direct Current Stimulation (tDCS) on Chronic Pelvic Pain |
https://ClinicalTrials.gov/show/NCT00554320 |
Completed |
Summa Health System |
2009-06-30 |
| NCT00552565 |
Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) |
https://ClinicalTrials.gov/show/NCT00552565 |
Completed |
AGI Therapeutics, Inc. |
2009-06-30 |
| NCT00542295 |
Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00542295 |
Completed |
Laboratoires Mayoly Spindler |
2008-07-31 |
| NCT00526903 |
Recurrent Abdominal Pain in Children |
https://ClinicalTrials.gov/show/NCT00526903 |
Completed |
Baylor College of Medicine |
2014-03-31 |
| NCT00486876 |
A Study of 3 Doses of Dextofisopam in Females With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00486876 |
Completed |
Pharmos |
2009-09-30 |
| NCT00477165 |
Citalopram in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00477165 |
Completed |
Stanford University |
2009-06-30 |
| NCT00468013 |
A Computer-Based Intervention for Medically Unexplained Physical Symptoms |
https://ClinicalTrials.gov/show/NCT00468013 |
Completed |
Rutgers, The State University of New Jersey |
2010-03-31 |
| NCT00461526 |
Diarrhea Predominant Irritable Bowel Syndrome in Females |
https://ClinicalTrials.gov/show/NCT00461526 |
Completed |
Bausch Health Americas, Inc. |
2007-12-31 |
| NCT00460811 |
Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) |
https://ClinicalTrials.gov/show/NCT00460811 |
Completed |
Ironwood Pharmaceuticals, Inc. |
2008-02-29 |
| NCT00454688 |
Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00454688 |
Completed |
Tioga Pharmaceuticals |
2007-11-30 |
| NCT00421707 |
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00421707 |
Completed |
GlaxoSmithKline |
2008-06-25 |
| NCT00401479 |
A Study To Investigate The Effect Of Solabegron (GW427353) On Gastrointestinal Transit In Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00401479 |
Completed |
GlaxoSmithKline |
NA |
| NCT00401258 |
An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00401258 |
Completed |
Mclean Hospital |
2008-02-29 |
| NCT00399542 |
Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation |
https://ClinicalTrials.gov/show/NCT00399542 |
Completed |
Mallinckrodt |
2006-07-31 |
| NCT00399438 |
A Study of BMS-562086 in Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00399438 |
Completed |
Bristol-Myers Squibb |
2007-10-31 |
| NCT00394186 |
A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT00394186 |
Completed |
GlaxoSmithKline |
NA |
| NCT00394173 |
Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) |
https://ClinicalTrials.gov/show/NCT00394173 |
Completed |
Novartis |
2007-10-31 |
| NCT00385099 |
Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00385099 |
Completed |
GlaxoSmithKline |
2007-10-15 |
| NCT00380250 |
Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation |
https://ClinicalTrials.gov/show/NCT00380250 |
Completed |
Mallinckrodt |
NA |
| NCT00376896 |
Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00376896 |
Completed |
GlaxoSmithKline |
2008-10-31 |
| NCT00374673 |
Efficacy of Transcranial Magnetic Stimulation (TMS) in Chronic Idiopathic Pain Disorders |
https://ClinicalTrials.gov/show/NCT00374673 |
Completed |
Hospital Ambroise Paré Paris |
2012-03-31 |
| NCT00370032 |
Study to Assess the Effect Of Alosetron On Mucosal Blood Flow |
https://ClinicalTrials.gov/show/NCT00370032 |
Completed |
GlaxoSmithKline |
2007-12-31 |
| NCT00368771 |
A Six-month Study to Compare Outcome Differences and Visceral Response … Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00368771 |
Completed |
University of California, Los Angeles |
2009-05-31 |
| NCT00355810 |
Probiotics for Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00355810 |
Completed |
Norwegian University of Science and Technology |
2006-04-30 |
| NCT00331994 |
EFESO - EFficacy Enterogermina Small Intestinal Bacterial Overgrowth |
https://ClinicalTrials.gov/show/NCT00331994 |
Completed |
Sanofi |
2008-07-31 |
| NCT00305968 |
Evaluation of Patient Education in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00305968 |
Completed |
Sorlandet Hospital HF |
2008-01-31 |
| NCT00269412 |
Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00269412 |
Completed |
Bausch Health Americas, Inc. |
2007-08-31 |
| NCT00268879 |
Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT00268879 |
Completed |
Alizyme |
2008-01-31 |
| NCT00259155 |
Rifaximin for the Treatment of Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00259155 |
Completed |
Cedars-Sinai Medical Center |
2007-01-31 |
| NCT00258193 |
Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS |
https://ClinicalTrials.gov/show/NCT00258193 |
Completed |
Ironwood Pharmaceuticals, Inc. |
NA |
| NCT00230581 |
8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS |
https://ClinicalTrials.gov/show/NCT00230581 |
Completed |
Dynogen Pharmaceuticals |
NA |
| NCT00220090 |
DARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in Constipation-Predominant Irritable Bowel Syndrome (C-IBS) |
https://ClinicalTrials.gov/show/NCT00220090 |
Completed |
Rottapharm |
2006-09-30 |
| NCT00215566 |
A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c |
https://ClinicalTrials.gov/show/NCT00215566 |
Completed |
Dynogen Pharmaceuticals |
NA |
| NCT00194922 |
Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in Treating Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT00194922 |
Completed |
Weill Medical College of Cornell University |
2006-11-30 |
| NCT00189813 |
A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS) |
https://ClinicalTrials.gov/show/NCT00189813 |
Completed |
Astellas Pharma Inc |
2005-12-31 |
| NCT00189696 |
Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS) |
https://ClinicalTrials.gov/show/NCT00189696 |
Completed |
Astellas Pharma Inc |
NA |
| NCT00189033 |
Dietary Interventions in Irritable Bowel Syndrome: Soluble, Insoluble or no Fibre? |
https://ClinicalTrials.gov/show/NCT00189033 |
Completed |
UMC Utrecht |
NA |
| NCT00167635 |
Nursing Management of Irritable Bowel Syndrome:Improving Outcomes |
https://ClinicalTrials.gov/show/NCT00167635 |
Completed |
University of Washington |
2008-02-29 |
| NCT00142987 |
Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS |
https://ClinicalTrials.gov/show/NCT00142987 |
Completed |
Novartis |
NA |
| NCT00139672 |
A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS. |
https://ClinicalTrials.gov/show/NCT00139672 |
Completed |
Pfizer |
2005-02-28 |
| NCT00135031 |
Efficacy of an Encapsulated Probiotic Bifidobacterium Infantis 35624 in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00135031 |
Completed |
Procter and Gamble |
2004-09-30 |
| NCT00130741 |
Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT00130741 |
Completed |
Hadassah Medical Organization |
NA |
| NCT00108446 |
Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00108446 |
Completed |
VA Office of Research and Development |
NA |
| NCT00101985 |
Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT00101985 |
Completed |
GlaxoSmithKline |
2005-07-31 |
| NCT00101725 |
A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00101725 |
Completed |
Bausch Health Americas, Inc. |
2005-11-30 |
| NCT00100425 |
Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00100425 |
Completed |
VA Office of Research and Development |
NA |
| NCT00093327 |
Acupuncture for Irritable Bowel Syndrome (IBS) |
https://ClinicalTrials.gov/show/NCT00093327 |
Completed |
National Center for Complementary and Integrative Health (NCCIH) |
NA |
| NCT00006157 |
Treatment of Functional Bowel Disorders |
https://ClinicalTrials.gov/show/NCT00006157 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
NA |
| NCT00067561 |
Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy |
https://ClinicalTrials.gov/show/NCT00067561 |
Completed |
GlaxoSmithKline |
2005-01-31 |
| NCT00067457 |
Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy |
https://ClinicalTrials.gov/show/NCT00067457 |
Completed |
GlaxoSmithKline |
2005-12-31 |
| NCT00065754 |
Brain Imaging and Pain in Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00065754 |
Completed |
University of Florida |
2007-12-31 |
| NCT00065403 |
Acupuncture for Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT00065403 |
Completed |
National Center for Complementary and Integrative Health (NCCIH) |
NA |
| NCT00796354 |
Constipation Associated With Irritable Bowel Syndrome (IBS-C) |
https://ClinicalTrials.gov/show/NCT00796354 |
Completed |
Norgine |
2010-02-28 |